Entries Written By Team AngelMD
One of the greatest strengths of AngelMD comes from our pipeline of investment opportunities. Today we are sharing one of them with you. Each hand-picked Premium Syndicate offering must meet rigorous standards, but VICIS is one of the strongest offerings we’ve ever had. The AngelMD community has invested in this cutting-edge sports helmet company in the past, and we’re excited to offer an opportunity to be part of the VICIS success story.
The story of VICIS started at the University of Washington. Sam Browd, a Pediatric Neurosurgeon, believed that sports-related concussions and chronic traumatic encephalopathy (CTE) needed better solutions. Dr. Browd partnered with a leading engineer and an executive with extensive medical device experience to form VICIS.
For the past three years, VICIS has been named the safest helmet in football as measured by the NFL and the NFL Players Association. The company has 28 NFL teams, more than 200 NCAA programs and 1500 high school programs using its ZERO1 helmet this year.
The VICIS success story is evident through its sales. Demand for the ZERO1 helmet, and for forthcoming VICIS products continues to grow. The balance of 2019 will focus on football. In 2020, the company is launching into hockey with direct involvement from leaders like Wayne Gretzky and Brett Hull. The company also plans to expand into lacrosse, soccer, and even military applications. 2021 will begin the expansion into new categories.
This is a great opportunity to invest in a company and a product that is directly responsible for the first notable improvements in concussions and subsequent cases of CTE. This AngelMD Premium Syndicate is raising a minimum of $2 million in a convertible note in advance of a Series C round. To date the company has raised $85 million.
To learn more, and to start join this Syndicate, please click here.
Please invite your colleagues to become part of the AngelMD community. The more subject matter experts that we have participating on the platform, the more great opportunities like VICIS that we can bring to our members.
In this episode, Tobin Arthur and Dr. Jeff Ross talk with Stephan Livera. Based in Sydney, Australia, Stephan is the host of The Bitcoin Podcast. He’s quite bullish on Bitcoin, and in this episode he provides us with some education about how the currency works, as well as how it can be used for investing. Make sure to check out the extensive show notes, and subscribe to The Bitcoin Podcast to stay up to date.
- Stephan Livera
- Austrian economics
- Eric Vorhees
- Bitcoin = Digital + Hard Money
- Settlement network + token (also called Bitcoin)
- Superior monetary characteristics plus characteristics not possible in the fiat money world
- Fiat money
- Carl Menger
- Keynesian Economics
- Open Source
- Bitcoin Full Node
- Stock to Flow Ratio
- Bitcoin Standard
- Plan B
- Podcast Episodes w/ Plan B: 67 & 86
- R Squared
- Malthusian (Thomas Malthus)
- Bitcoin Market Cap
- Alt Coin
- Unix Philosophy
- Smart Contracts
- Lightning Network
- Inventing Bitcoin
- The Little Bitcoin Book
- Mastering Bitcoin
The following companies all joined AngelMD in September of 2019. Make sure to follow the ones that match your areas of interest to keep up with their progress.
Tobin flies solo this week, talking with Dr. Joseph Macaluso. After a long career in medicine, Dr. Macaluso retired and now spends his time advising, evaluating, and investing in promising healthcare startups. In this interview he discusses his career, what led him to the path of investing, and the benefits served by technology-driven investment platforms.
In this episode of Innovation4Alpha, Dr. Ross and Tobin Arthur interview Tobias Carlisle. Tobias is the founder of The Acquirer’s Multiple, which is a program that helps investors identify deeply undervalued stocks.
On top of founding the program, Tobias also manages a fund and an ETF under the Acquirer’s Fund brand, and he is the best-selling author of the book The Acquirer’s Multiple.